Integer Holdings Corporation (NYSE:ITGR) Receives $109.86 Average Price Target from Analysts

by · The Markets Daily

Integer Holdings Corporation (NYSE:ITGR – Get Free Report) has been assigned a consensus recommendation of “Hold” from the fourteen analysts that are covering the stock, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $109.8571.

Several equities analysts recently issued reports on ITGR shares. Benchmark cut Integer from a “buy” rating to a “hold” rating in a research note on Thursday, August 13th. Raymond James Financial cut Integer from a “moderate buy” rating to a “hold” rating in a report on Monday, August 3rd. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Piper Sandler downgraded Integer from an “overweight” rating to a “hold” rating and set a $127.00 target price for the company. in a research report on Monday, August 3rd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th.

View Our Latest Analysis on ITGR

Integer Stock Performance

Shares of ITGR opened at $126.20 on Friday. Integer has a 52-week low of $62.00 and a 52-week high of $126.79. The company has a quick ratio of 2.41, a current ratio of 3.73 and a debt-to-equity ratio of 0.75. The firm has a market cap of $4.29 billion, a price-to-earnings ratio of 34.48, a PEG ratio of 2.40 and a beta of 0.62. The business’s 50 day moving average is $115.55 and its two-hundred day moving average is $97.92.

Integer (NYSE:ITGR – Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. During the same period last year, the business earned $1.55 EPS. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. Analysts forecast that Integer will post 6.09 EPS for the current fiscal year.

Insider Buying and Selling

In other Integer news, insider Andrew Senn sold 9,408 shares of Integer stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the transaction, the insider directly owned 5,405 shares in the company, valued at approximately $682,651.50. The trade was a 63.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Sequoia Financial Advisors LLC increased its stake in shares of Integer by 4.7% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,180 shares of the medical equipment provider’s stock worth $297,000 after purchasing an additional 142 shares during the last quarter. Corient Private Wealth LP lifted its holdings in shares of Integer by 10.7% during the second quarter. Corient Private Wealth LP now owns 48,981 shares of the medical equipment provider’s stock worth $4,577,000 after buying an additional 4,742 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Integer during the 2nd quarter valued at $215,000. Bluefin Capital Management LLC raised its position in shares of Integer by 263.6% during the second quarter. Bluefin Capital Management LLC now owns 30,332 shares of the medical equipment provider’s stock valued at $2,835,000 after buying an additional 21,990 shares during the last quarter. Finally, Hsbc Holdings PLC bought a new stake in shares of Integer in the 2nd quarter worth approximately $3,292,000. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Company Profile

(Get Free Report)

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.

Featured Stories